Form 4: Assertio Holdings Director Emany Receives Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Sravan Kumar Emany acquired stock options and restricted stock units in Assertio Holdings, Inc. on May 7, 2025, according to a Form 4 filing.

Summary

  • Sravan Kumar Emany, a director of Assertio Holdings, Inc., reported changes in beneficial ownership on May 7, 2025.
  • Emany acquired 53,750 shares of common stock and 81,225 stock options.
  • The stock options have an exercise price of $0.6171 and expire on May 7, 2035.
  • The restricted stock units vest on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting.
  • These transactions occurred in accordance with the Issuer's Nonemployee Director Compensation & Grant Policy.
  • Following the reported transactions, Emany beneficially owns 285,070 shares of common stock and 81,225 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports routine insider transactions related to director compensation. It doesn't indicate any significant positive or negative developments for the company.

Positives

  • The grant of stock options and restricted stock units aligns the director's interests with those of the shareholders.
  • The vesting schedule incentivizes continued service and contribution to the company's success.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies as part of executive compensation packages. These grants are designed to align management's interests with those of shareholders.

Comparison to Industry Standards

  • Director compensation packages often include a mix of salary, stock options, and restricted stock units.
  • The vesting schedules and exercise prices are typical for such grants, aiming to incentivize long-term performance.
  • Comparing Assertio Holdings' director compensation with similar pharmaceutical companies would provide a more detailed benchmark.

Stakeholder Impact

  • The grant of stock options and restricted stock units can positively impact shareholders by aligning director incentives with company performance.

Key Dates

DateDescription
05/07/2025Date of transaction: acquisition of common stock and stock options.
05/07/2035Expiration date of the stock options.
05/09/2025Date of signature on the Form 4 filing.

Keywords

Form 4, beneficial ownership, stock options, restricted stock units, director compensation, Assertio Holdings, ASRT, Emany

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.